Raj Denhoy analyst

Currently out of the existing stock ratings of Raj Denhoy, 145 are a BUY (90.06%), 15 are a HOLD (9.32%), 1 are a SELL (0.62%).

Raj Denhoy

Work Performance Price Targets & Ratings Chart

Analyst Raj Denhoy, currently employed carries an average stock price target met ratio of 69.91% that have a potential upside of 22.59% achieved within 291 days. Previously, Raj Denhoy worked at JEFFERIES.

Raj Denhoy’s has documented 348 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on STAA, STAAR Surgical Company at 15-Sep-2023.

Wall Street Analyst Raj Denhoy

Analyst best performing recommendations are on IART (INTEGRA LIFESCIENCES HOLDINGS).
The best stock recommendation documented was for ESTA (ESTABLISHMENT LABS HOLDINGS) at 1/8/2021. The price target of $50 was fulfilled within 7 days with a profit of $12.09 (31.89%) receiving and performance score of 45.56.

Average potential price target upside

ABMD ABIOMED BSX Boston Scientific Corp DXCM DexCom ESTA Establishment Labs Holdings EW Edwards Lifesciences Corp HOLX Hologic IART Integra LifeSciences Holdings LIVN LivaNova PLC LNTH Lantheus Holdings MDT Medtronic PLC MDWD Mediwound Ltd NUVA NuVasive PODD Insulet TFX Teleflex orporated WMGI Wright Medical Group N.V ZBH Zimmer Biomet Holdings ABT Abbott Laboratories SYK Stryker AXGN Axogen RMD ResMed COO The Cooper Companies . Common Stock HAE Haemonetics ATEC Alphatec Holdings STAA STAAR Surgical Company PROF Profound Medical Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$388

$6.98 (1.83%)

$355

2 years 19 days ago
(02-Nov-2022)

2/5 (40%)

$14.49 (3.88%)

88

Hold

$380

$-1.02 (-0.27%)

$235

2 years 19 days ago
(02-Nov-2022)

1/2 (50%)

$6.49 (1.74%)

36

Hold

$380

$-1.02 (-0.27%)

$350

2 years 20 days ago
(01-Nov-2022)

24/41 (58.54%)

$2.18 (0.58%)

138

Buy

$300

$-81.02 (-21.26%)

$425

2 years 1 months 9 days ago
(12-Oct-2022)

1/2 (50%)

$57.23 (23.57%)

20

Sell

$235

$-146.02 (-38.32%)

$275

2 years 4 months 6 days ago
(15-Jul-2022)

6/8 (75%)

$-33.23 (-12.39%)

142

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Raj Denhoy?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?